Midwest Trust’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
Midwest Trust's CRL Position: Q3 2026 in Review
Midwest Trust reduced its Charles River Laboratories (CRL) stake by 0.9% in Q3 2026, selling an estimated $63.5K and leaving 26,617 shares worth $7.85M. The position accounts for 0.09% of the portfolio, ranked #172.
Midwest Trust first reported a position in CRL in Q2 2025 and has held it in 6 quarters since. 91 funds tracked by Wall St. Rank hold CRL as of Q3 2026.
- Midwest Trust held 26,617 shares of Charles River Laboratories worth $7.85M as of Q3 2026.
- Midwest Trust sold 241 Charles River Laboratories shares in Q3 2026, an estimated $63.5K.
- Charles River Laboratories made up 0.09% of Midwest Trust's portfolio in Q3 2026, its #172 holding.
- Midwest Trust first reported a position in Charles River Laboratories in Q2 2025 and has held it in 6 quarters since.
- 91 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2026.
Based on Midwest Trust's 13F filing for Q3 2026, filed 22 Oct 2026.